Figure 6.
Drug sensitivity analysis between the two subgroups. (A) The 10 chemotherapeutic agents showed different sensitivities for patients in the high-risk and low-risk groups. (B) Chemotherapeutic agents sensitive to high-risk patients. (C) Chemotherapeutic agents sensitive to low-risk patients.
